Back
New York Times Vs. Regencell Bioscience Holdings Industry Stock Comparison
Buy
62
NYT
New York Times
Last Price:
$53.86
Seasonality Move:
-0.68%
Sell
22
RGC
Regencell Bioscience Holdings
Last Price:
$14.93
Seasonality Move:
-2.16%
Buy
62
New York Times (NYT)
is a Buy
Is New York Times a Buy, Sell or Hold?
-
The current New York Times [NYT] share price is $53.85. The Score for NYT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NYT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $14.86. The Score for RGC is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NYT Stock Price Chart
What is New York Times's stock price today?
-
The New York Times share price today is $53.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight buying pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $14.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing selling pressure, which indicates risk of future bearish movement.
NYT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.17 | Buy |
Relative Strength Index (14 RSI): | 37.94 | Sell |
Chaikin Money Flow: | 1019799 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.53 - 56.43) | Sell |
Bollinger Bands (100): | (48.68 - 55.58) | Buy |
RGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.16 | Buy |
Relative Strength Index (14 RSI): | 45.8 | Sell |
Chaikin Money Flow: | -579444 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.26 - 41.02) | Sell |
Bollinger Bands (100): | (-3.49 - 22.73) | Buy |
NYT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.36 | Sell |
20-day SMA: | 55.51 | Sell |
50-day SMA: | 55.31 | Sell |
200-day SMA: | 52.94 | Buy |
8-day EMA: | 47.48 | Buy |
20-day EMA: | 30.38 | Buy |
50-day EMA: | 15.14 | Buy |
200-day EMA: | 4.25 | Buy |
RGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.82 | Sell |
20-day SMA: | 20.87 | Sell |
50-day SMA: | 18.52 | Sell |
200-day SMA: | 4.88 | Buy |
8-day EMA: | 13.16 | Buy |
20-day EMA: | 8.56 | Buy |
50-day EMA: | 4.3 | Buy |
200-day EMA: | 1.21 | Buy |
New York Times Earnings Growth & NYT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.06 per share, an increase this year of $0.28 per share, and an increase next year of $0.21 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
New York Times Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regencell Bioscience Holdings Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |